Cargando…

Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer

BACKGROUND: While several molecular markers of bladder cancer prognosis have been identified, the limited value of current prognostic markers has created the need for new molecular indicators of bladder cancer outcomes. The aim of this study was to identify genetic signatures associated with disease...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Wun-Jae, Kim, Eun-Jung, Kim, Seon-Kyu, Kim, Yong-June, Ha, Yun-Sok, Jeong, Pildu, Kim, Min-Ju, Yun, Seok-Joong, Lee, Keon Myung, Moon, Sung-Kwon, Lee, Sang-Cheol, Cha, Eun-Jong, Bae, Suk-Chul
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821358/ https://www.ncbi.nlm.nih.gov/pubmed/20059769 http://dx.doi.org/10.1186/1476-4598-9-3

Ejemplares similares

GSTT1 as a Prognosticator for Recurrence and Progression in Patients with Non-Muscle-Invasive Bladder Cancer
por: Ha, Yun-Sok, et al.
Publicado: (2010)

GSTM1 Tissue Genotype as a Recurrence Predictor in Non-muscle Invasive Bladder Cancer
por: Ha, Yun-Sok, et al.
Publicado: (2011)

Assess the expression of ubiquitin specific protease USP2a for bladder cancer diagnosis
por: Jeong, Pildu, et al.
Publicado: (2015)

Identification of Gene Expression Signature Modulated by Nicotinamide in a Mouse Bladder Cancer Model
por: Kim, Seon-Kyu, et al.
Publicado: (2011)

Identification of Pro-Inflammatory Cytokines Associated with Muscle Invasive Bladder Cancer; The Roles of IL-5, IL-20, and IL-28A
por: Lee, Se-Jung, et al.
Publicado: (2012)

Identification of S100A8-correlated genes for prediction of disease progression in non-muscle invasive bladder cancer
por: Kim, Seon-Kyu, et al.
Publicado: (2010)

Granular Cell Tumor of the Urinary Bladder
por: Kang, Ho-Won, et al.
Publicado: (2010)

Genetic variation of the PSCA gene (rs2294008) is not associated with the risk of prostate cancer
por: Lee, Il-Seok, et al.
Publicado: (2017)

Novel Combination Markers for Predicting Survival in Patients with Muscle Invasive Bladder Cancer: USP18 and DGCR2
por: Kim, Ye-Hwan, et al.
Publicado: (2014)

mRNA Expression of S100A8 as a Prognostic Marker for Progression of Non-Muscle-Invasive Bladder Cancer
por: Ha, Yun-Sok, et al.
Publicado: (2010)

Diagnosis of bladder cancer and prediction of survival by urinary metabolomics
por: Jin, Xing, et al.
Publicado: (2014)

FAM70B as a Novel Prognostic Marker for Cancer Progression and Cancer-Specific Death in Muscle-Invasive Bladder Cancer
por: Kang, Ho-Won, et al.
Publicado: (2012)

Comparison of Metabolic Risk Factors in Urolithiasis Patients according to Family History
por: Park, Cheol, et al.
Publicado: (2010)

How do we manage high-grade T1 bladder cancer? Conservative or aggressive therapy?
por: Yun, Seok Joong, et al.
Publicado: (2016)

Transcriptomic features of primary prostate cancer and their prognostic relevance to castration-resistant prostate cancer
por: Yun, Seok Joong, et al.
Publicado: (2017)

UBE2C cell-free RNA in urine can discriminate between bladder cancer and hematuria
por: Kim, Won Tae, et al.
Publicado: (2016)

Forkhead box O-class 1 and Forkhead box G1 as Prognostic Markers for Bladder Cancer
por: Kim, Tae-Hwan, et al.
Publicado: (2009)

Urinary cell-free nucleic acid IQGAP3: a new non-invasive diagnostic marker for bladder cancer
por: Kim, Won Tae, et al.
Publicado: (2018)

A Molecular Signature Determines the Prognostic and Therapeutic Subtype of Non-Muscle-Invasive Bladder Cancer Responsive to Intravesical Bacillus Calmette-Guérin Therapy
por: Kim, Seon-Kyu, et al.
Publicado: (2021)

Value of urinary topoisomerase-IIA cell-free DNA for diagnosis of bladder cancer
por: Kim, Ye-Hwan, et al.
Publicado: (2016)

Role of Exosomal miRNA in Bladder Cancer: A Promising Liquid Biopsy Biomarker
por: Piao, Xuan-Mei, et al.
Publicado: (2021)

Phosphaturia as a Promising Predictor of Recurrent Stone Formation in Patients with Urolithiasis
por: Ha, Yun-Sok, et al.
Publicado: (2010)

Alpha-Methylacyl-Coenzyme A Racemase-Expressing Urachal Adenocarcinoma of the Abdominal Wall
por: Ha, Yun-Sok, et al.
Publicado: (2010)

Nutritional status assessed by the Controlling Nutritional Status (CONUT) score as a predictor of recurrence of urolithiasis
por: Lee, Hee Youn, et al.
Publicado: (2021)

Impact of Transobturator Tape Treatment on Overactive Bladder Symptoms, Particularly Nocturia, in Patients With Mixed Urinary Incontinence
por: Lee, Sang Keun, et al.
Publicado: (2014)

A novel tumor suppressing gene, ARHGAP9, is an independent prognostic biomarker for bladder cancer
por: Piao, Xuan-Mei, et al.
Publicado: (2020)

Chronological Trends in Clinical and Urinary Metabolic Features over 20 Years in Korean Urolithiasis Patients
por: Kang, Ho Won, et al.
Publicado: (2017)

Cell-Free microRNA-214 From Urine as a Biomarker for Non-Muscle-Invasive Bladder Cancer
por: Kim, Sung Min, et al.
Publicado: (2013)

Generation of Whole-Genome Sequencing Data for Comparing Primary and Castration-Resistant Prostate Cancer
por: Park, Jong-Lyul, et al.
Publicado: (2018)

Expectant Management of Ureter Stones: Outcome and Clinical Factors of Spontaneous Passage in a Single Institution's Experience
por: Tchey, Dong-Un, et al.
Publicado: (2011)

Utility of a Molecular Signature for Predicting Recurrence and Progression in Non-Muscle-Invasive Bladder Cancer Patients: Comparison with the EORTC, CUETO and 2021 EAU Risk Groups
por: Piao, Xuan-Mei, et al.
Publicado: (2022)

A high basal metabolic rate is an independent predictor of stone recurrence in obese patients
por: Kang, Ho Won, et al.
Publicado: (2021)

Metabolic Pathway Signatures Associated with Urinary Metabolite Biomarkers Differentiate Bladder Cancer Patients from Healthy Controls
por: Kim, Won Tae, et al.
Publicado: (2016)

Identification of differentially expressed miRNAs and miRNA-targeted genes in bladder cancer
por: Lee, Jong-Young, et al.
Publicado: (2018)

Role of the Epithelial-Mesenchymal Transition in Bladder Cancer: From Prognosis to Therapeutic Target
por: Yun, Seok Joong, et al.
Publicado: (2013)

The c-MET Network as Novel Prognostic Marker for Predicting Bladder Cancer Patients with an Increased Risk of Developing Aggressive Disease
por: Kim, Young-Won, et al.
Publicado: (2015)

CDC6 mRNA Expression Is Associated with the Aggressiveness of Prostate Cancer
por: Kim, Ye-Hwan, et al.
Publicado: (2018)

A novel urinary mRNA signature using the droplet digital polymerase chain reaction platform improves discrimination between prostate cancer and benign prostatic hyperplasia within the prostate-specific antigen gray zone
por: Kang, Ho Won, et al.
Publicado: (2020)

Bacteria for Treatment: Microbiome in Bladder Cancer
por: Min, Kyungchan, et al.
Publicado: (2022)

Prognostic Significance of CREB-Binding Protein and CD81 Expression in Primary High Grade Non-Muscle Invasive Bladder Cancer: Identification of Novel Biomarkers for Bladder Cancer Using Antibody Microarray
por: Lee, Myung-Shin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5b4beaveomcq243b1a0beueo1n